S. 340 · 116th Congress
A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
- Stage
- Introduced
- Sponsor
- Patrick Leahy
- Introduced
- 2019-02-05
- Latest action
- 2019-02-06 · Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
Subjects
Health
Civil actions and liability
Licensing and registrations
Prescription drugs
Drug safety, medical device, and laboratory regulation
Product development and innovation